Interferon alpha for Treatment of Chronic Myeloid Leukemia

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|12|3|420-428

ISSN： 1389-4501

Source： Current Drug Targets, Vol.12, Iss.3, 2011-03, pp. : 420-428

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment options for chronic myeloid leukemia

By Tanaka Maria Florencia   Kantarjian Hagop   Cortes Jorge   Ohanian Maro   Jabbour Elias  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 6, 2012-04 ,pp. : 815-828

Informa Healthcare

Access to resources Recommend Favorite

Treatment of chronic myeloid leukemia when imatinib fails

By Hehlmann Rüdiger   Jung-Munkwitz Susanne   Saußele Susanne  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 2, 2011-02 ,pp. : 269-283

Informa Healthcare

Access to resources Recommend Favorite

Mathematical Modeling of Genesis and Treatment of Chronic Myeloid Leukemia

By  

Cells Tissues Organs, Vol. 188, Iss. 1-2, 2008-02 ,pp. : 236-247

Karger

Access to resources Recommend Favorite

Nilotinib for the treatment of Philadelphia-chromosome-positive chronic myeloid leukemia

By Fullmer Amber   Kantarjian Hagop   Cortes Jorge   Jabbour Elias  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 18, 2010-12 ,pp. : 3065-3072

Informa Healthcare

Access to resources Recommend Favorite

New Tyrosine Kinase Inhibitors in the Treatment of Chronic Myeloid Leukemia

By  

Current Pharmaceutical Biotechnology, Vol. 7, Iss. 5, 2006-10 ,pp. : 371-379

Bentham Science Publishers

Access to resources Recommend Favorite